Regeneron Pharmaceuticals Inc (REGN)

Fixed asset turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	US$ in thousands	14,202,000	13,044,200	12,113,500	16,014,400	8,440,200
Property, plant and equipment	US$ in thousands	4,008,500	3,540,700	3,142,700	3,482,200	3,221,600
Fixed asset turnover		3.54	3.68	3.85	4.60	2.62

December 31, 2024 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $14,202,000K ÷ $4,008,500K
= 3.54

The fixed asset turnover ratio for Regeneron Pharmaceuticals Inc has shown an increasing trend over the past five years. In December 31, 2020, the ratio stood at 2.62, and it significantly improved to 4.60 by December 31, 2021. However, there was a slight decline in the ratio to 3.85 by December 31, 2022. Subsequently, the ratio further decreased to 3.68 by December 31, 2023, and then to 3.54 by December 31, 2024.

This trend suggests that Regeneron Pharmaceuticals Inc has been effectively utilizing its fixed assets to generate sales revenue, as indicated by the rise in the ratio from 2020 to 2021. However, the fluctuations in the following years indicate some variability in the company's efficiency in utilizing its fixed assets to generate sales. Further analysis is warranted to understand the factors influencing these fluctuations and to assess the company's overall asset management effectiveness.